Virus-induced senescence is a driver and therapeutic target in COVID-19
Soyoung Lee,Yong Yu,Jakob Trimpert,Fahad Benthani,Mario Mairhofer,Paulina Richter-Pechanska,Emanuel Wyler,Dimitri Belenki,Sabine Kaltenbrunner,Maria Pammer,Lea Kausche,Theresa C. Firsching,Kristina Dietert,Michael Schotsaert,Carles Martínez-Romero,Gagandeep Singh,Séverine Kunz,Daniela Niemeyer,Riad Ghanem,Helmut J. F. Salzer,Christian Paar,Michael Mülleder,Melissa Uccellini,Edward G. Michaelis,Amjad Khan,Andrea Lau,Martin Schönlein,Anna Habringer,Josef Tomasits,Julia M. Adler,Susanne Kimeswenger,Achim D. Gruber,Wolfram Hoetzenecker,Herta Steinkellner,Bettina Purfürst,Reinhard Motz,Francesco Di Pierro,Bernd Lamprecht,Nikolaus Osterrieder,Markus Landthaler,Christian Drosten,Adolfo García-Sastre,Rupert Langer,Markus Ralser,Roland Eils,Maurice Reimann,Dorothy N. Y. Fan,Clemens A. Schmitt
DOI: https://doi.org/10.1038/s41586-021-03995-1
IF: 64.8
2021-09-13
Nature
Abstract:Derailed cytokine and immune cell networks account for organ damage and clinical severity of COVID-191–4. Here we show that SARS-CoV-2, like other viruses, evokes cellular senescence as a primary stress response in infected cells. Virus-induced senescence (VIS) is indistinguishable from other forms of cellular senescence and accompanied by a senescence-associated secretory phenotype (SASP), composed of pro-inflammatory cytokines, extracellular matrix-active factors and pro-coagulatory mediators5–7. COVID-19 patients displayed markers of senescence in their airway mucosa in situ and elevated serum levels of SASP factors. Mirroring COVID-19 hallmark features such as macrophage and neutrophil infiltration, endothelial damage and widespread thrombosis in affected lung tissue1,8,9, in vitro assays demonstrated macrophage activation with SASP-reminiscent secretion, complement lysis and SASP-amplifying secondary senescence of endothelial cells, neutrophil extracellular trap (NET) formation as well as activation of platelets and the clotting cascade in response to supernatant of VIS cells, including SARS-CoV-2-induced senescence. Senolytics such as Navitoclax and Dasatinib/Quercetin selectively eliminated VIS cells, mitigated COVID-19-reminiscent lung disease and reduced inflammation in SARS-CoV-2-driven hamster and mouse models. Our findings mark VIS as pathogenic trigger of COVID-19-related cytokine escalation and organ damage, and suggest senolytic targeting of virus-infected cells as a novel treatment option against SARS-CoV-2 and perhaps other viral infections.
multidisciplinary sciences